The 7 Most Undervalued Under-$10 Stocks to Buy in July 2024

In This Article:

Think it’s too late to find true bargains in this raging bull market? You might be surprised.

In fact, plenty of opportunities in low-priced stocks are waiting to be found.

As of July 2024, more than 2,600 stocks are listed on major U.S. stock exchanges with a share price of $10 or less. Of course, many of these aren’t great investment options. Most penny stocks and low-priced names end up there due to major issues with the underlying businesses.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

But, some real diamonds in the rough can be found. Examine seven of the most promising stocks under $10 to buy this summer.

United Microelectronics (UMC)

Semiconductors chips and blurred UMC United Microelectronics Corporation logo.
Semiconductors chips and blurred UMC United Microelectronics Corporation logo.

Source: Ascannio via shutterstock

United Microelectronics (NYSE:UMC) is the world’s fourth-largest semiconductor foundry business by market share. While Taiwan Semiconductor Manufacturing (NYSE:TSM) tends to get all the attention, UMC has built a nice business for itself as well.

In fact, United Microelectronics generates more than $8 billion in annual revenues. While not the industry big dog, it has sufficient operating scale to achieve strong profitability. In fact, UMC stock trades for just 11 times earnings and a mere six times enterprise value to EBITDA. That’s tremendous, considering the lofty valuations for most other semiconductor stocks.

As applications such as artificial intelligence (AI), IoT and connected cars continue to take off, the foundry market should grow substantially. And, United Microelectronics is poised to benefit as companies increasingly look to diversify their supply chains away from TSM. Moreover, UMC stock offers a generous 5.5% dividend yield.

Ambev (ABEV)

Ambev brewing company
Ambev brewing company

Source: rmcarvalhobsb / Shutterstock.com

Ambev (NYSE:ABEV) is Brazil’s brewing giant. The company is a subsidiary of Anheuser-Busch InBev (NYSE:BUD), operating for the firm in leading South American markets such as Brazil and Argentina.

Investors have shunned Anheuser-Busch InBev due to its large debtload, political controversies and soft operating results. But Ambev is a totally different situation.

Ambev maintains a net cash balance, a stark contrast to Anheuser-Busch’s debt-driven approach. It has largely avoided the sorts of boycotts that tripped up its corporate parent. Also, the issues hampering U.S. beer consumption, such as marijuana legalization and the rise of GLP-1 weight loss drugs, haven’t impacted beer sales nearly as much in South America.

Ambev shares have fallen 34% over the past 12 months. A slowing Brazilian economy along with dismal sentiment in the alcohol sector are largely to blame. However, these factors have pushed the stock down to just 11 times forward earnings, which is a real steal for a dominant consumer business.